Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
+466K
-
Total reported value, excl. options
-
$319M
-
Value change
-
+$9.97M
-
Put/Call ratio
-
3.15
-
Number of buys
-
37
-
Number of sells
-
-20
-
Price
-
$20.78
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q2 2021
80 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q2 2021.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 142M outstanding shares and own 10.86% of the company stock.
Largest 10 shareholders include FMR LLC (2.42M shares), ORBIMED ADVISORS LLC (2.26M shares), BlackRock Inc. (1.31M shares), ALKEON CAPITAL MANAGEMENT LLC (1.04M shares), Knoll Capital Management, LLC (1.03M shares), VANGUARD GROUP INC (845K shares), FRANKLIN RESOURCES INC (830K shares), Rock Springs Capital Management LP (702K shares), EMERALD MUTUAL FUND ADVISERS TRUST (653K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (644K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.